Muscle hypotonia
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
Prevalence and architecture of de novo mutations in developmental disorders.
|
28135719 |
2017 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
The MSL complex: juggling RNA-protein interactions for dosage compensation and beyond.
|
25900149 |
2015 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
Mof-associated complexes have overlapping and unique roles in regulating pluripotency in embryonic stem cells and during differentiation.
|
24898753 |
2014 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
Structural and biochemical studies on the chromo-barrel domain of male specific lethal 3 (MSL3) reveal a binding preference for mono- or dimethyllysine 20 on histone H4.
|
20943666 |
2010 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
Corecognition of DNA and a methylated histone tail by the MSL3 chromodomain.
|
20657587 |
2010 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
The MRG domain mediates the functional integration of MSL3 into the dosage compensation complex.
|
15988010 |
2005 |
Muscle hypotonia
|
0.400 |
GeneticVariation
|
phenotype |
CLINVAR |
A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16.
|
16227571 |
2005 |
Developmental Disabilities
|
0.300 |
Biomarker
|
group |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Child Development Deviations
|
0.300 |
Biomarker
|
disease |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Child Development Disorders, Specific
|
0.300 |
Biomarker
|
disease |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Unsteady
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Spastic gait
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Shuffling
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Athetotic
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Charcot Gait
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Festinating
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Cerebellar ataxic gait
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Hemiplegic
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Scissors
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Waddling gait
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Feeding difficulties
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Rigid
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Gait, Broadened
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |
Facies
|
0.300 |
Biomarker
|
group |
CTD_human |
De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
|
30224647 |
2018 |